MY114424A - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors,their preparation and pharmaceutical compositions containing them - Google Patents
Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- MY114424A MY114424A MYPI96001383A MYPI19961383A MY114424A MY 114424 A MY114424 A MY 114424A MY PI96001383 A MYPI96001383 A MY PI96001383A MY PI19961383 A MYPI19961383 A MY PI19961383A MY 114424 A MY114424 A MY 114424A
- Authority
- MY
- Malaysia
- Prior art keywords
- group
- hydrogen
- alkyl
- formula
- pyrazolecarboxamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
- C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
- C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/47—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having at least one of the sulfo groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9504350A FR2732967B1 (fr) | 1995-04-11 | 1995-04-11 | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY114424A true MY114424A (en) | 2002-10-31 |
Family
ID=9478010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI96001383A MY114424A (en) | 1995-04-11 | 1996-04-11 | Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors,their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| US (6) | US5723483A (OSRAM) |
| EP (2) | EP0820444A1 (OSRAM) |
| JP (1) | JP3061644B2 (OSRAM) |
| KR (1) | KR100366118B1 (OSRAM) |
| CN (1) | CN1072210C (OSRAM) |
| AR (1) | AR003940A1 (OSRAM) |
| AU (1) | AU709119B2 (OSRAM) |
| CA (1) | CA2220827A1 (OSRAM) |
| CZ (1) | CZ292255B6 (OSRAM) |
| EE (1) | EE9700264A (OSRAM) |
| FR (1) | FR2732967B1 (OSRAM) |
| HU (1) | HUP9801435A3 (OSRAM) |
| IL (1) | IL117860A0 (OSRAM) |
| IN (1) | IN185700B (OSRAM) |
| IS (1) | IS4582A (OSRAM) |
| MY (1) | MY114424A (OSRAM) |
| NO (1) | NO310071B1 (OSRAM) |
| NZ (1) | NZ307227A (OSRAM) |
| PL (1) | PL188077B1 (OSRAM) |
| RU (1) | RU2195455C2 (OSRAM) |
| SK (1) | SK136797A3 (OSRAM) |
| TR (1) | TR199701146T1 (OSRAM) |
| TW (1) | TW411332B (OSRAM) |
| UA (1) | UA66750C2 (OSRAM) |
| WO (1) | WO1996032382A1 (OSRAM) |
| ZA (1) | ZA962886B (OSRAM) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2732967B1 (fr) | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
| US6506747B1 (en) * | 1998-06-05 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents |
| DE10146867A1 (de) * | 2001-09-24 | 2003-04-24 | Bayer Ag | Tetrahydroisochinoline |
| WO2003090680A2 (en) * | 2002-04-23 | 2003-11-06 | Axys Pharmaceuticals, Inc. | Novel phenyl derivatives as inducers of apoptosis |
| GB0225548D0 (en) * | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
| FR2847160A1 (fr) * | 2002-11-20 | 2004-05-21 | Oreal | Composition capillaire contenant un compose pyrasol-carboxamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute |
| JP4926402B2 (ja) | 2002-11-27 | 2012-05-09 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | サイトカインインヒビターとしての１，２，３−トリアゾールアミド誘導体 |
| US7078419B2 (en) | 2003-03-10 | 2006-07-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
| RU2337099C2 (ru) * | 2003-04-03 | 2008-10-27 | Мерк Патент Гмбх | Карбонильные соединения |
| US20060079566A1 (en) * | 2003-10-03 | 2006-04-13 | Ching-Shih Chen | PDK-1/Akt signaling inhibitors |
| GB0323584D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| EP1675585A2 (en) * | 2003-10-17 | 2006-07-05 | Tanabe Seiyaku Co., Ltd. | Large conductance calcium-activated k channel opener |
| ATE501128T1 (de) | 2003-12-03 | 2011-03-15 | Boehringer Ingelheim Pharma | 1,2,3-triazolamidderivate als inhibitoren der cytokinproduktion |
| KR20060131906A (ko) * | 2004-02-20 | 2006-12-20 | 아스트라제네카 아베 | Ｃｂ1 조절제로서 유용한 3-치환 1,5-디페닐피라졸 유도체 |
| HRP20090334T1 (en) | 2004-03-09 | 2009-07-31 | Boehringer Ingelheim Pharmaceuticals Inc. | 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| US7285545B2 (en) | 2004-05-03 | 2007-10-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
| GB0410121D0 (en) * | 2004-05-06 | 2004-06-09 | Glaxo Group Ltd | Compounds |
| US7485657B2 (en) * | 2004-05-12 | 2009-02-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| US7531560B2 (en) * | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| US20080146614A1 (en) * | 2004-12-23 | 2008-06-19 | Leifeng Cheng | Therapeutic Agents |
| RU2304967C2 (ru) * | 2005-05-26 | 2007-08-27 | Государственное общеобразовательное учреждение высшего профессионального образования Казанский государственный медицинский университет | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки |
| GB0514738D0 (en) * | 2005-07-19 | 2005-08-24 | Astrazeneca Ab | Therapeutic agents |
| WO2007107470A2 (en) * | 2006-03-22 | 2007-09-27 | F. Hoffmann-La Roche Ag | Pyrazoles as 11-beta-hsd-1 |
| WO2008072724A1 (ja) * | 2006-12-14 | 2008-06-19 | Taisho Pharmaceutical Co., Ltd. | ピラゾール誘導体 |
| EP2178845B1 (en) * | 2007-07-17 | 2013-06-19 | F. Hoffmann-La Roche AG | Inhibitors of 11b-hydroxysteroid dehydrogenase |
| WO2010079158A1 (en) | 2009-01-07 | 2010-07-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment, the prognostic assessment and the detection of breast cancer |
| CN102482228A (zh) | 2009-07-17 | 2012-05-30 | 盐野义制药株式会社 | 含有内酰胺或苯磺酰胺化合物的药物 |
| US20110028624A1 (en) * | 2009-07-30 | 2011-02-03 | Genovique Specialties Holdings Corporation | Polymer Compositions That Include High Solvating Plasticizer And Surfactant |
| EP2740726A1 (en) * | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
| US20170174633A1 (en) * | 2014-03-25 | 2017-06-22 | Research Triangle Institute | Pyrazole compounds selective for neurotensin 2 receptor |
| AU2015269247B2 (en) | 2014-06-06 | 2019-10-24 | Research Triangle Institute | Apelin receptor (APJ) agonists and uses thereof |
| EP2954934A1 (en) | 2014-06-11 | 2015-12-16 | 3B Pharmaceuticals GmbH | Conjugate comprising a neurotensin receptor ligand and use thereof |
| RU2743781C2 (ru) * | 2014-06-10 | 2021-02-25 | 3Б Фармасьютикалз Гмбх | Конъюгат, содержащий лиганд рецепторов нейротензина, и его применение |
| EP2954933A1 (en) | 2014-06-10 | 2015-12-16 | 3B Pharmaceuticals GmbH | Conjugate comprising a neurotensin receptor ligand |
| US10100059B2 (en) | 2015-12-09 | 2018-10-16 | Research Triangle Institute | Apelin receptor (APJ) agonists and uses thereof |
| EP3279197A1 (en) | 2016-08-03 | 2018-02-07 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Diagnosis, treatment and prevention of neurotensin receptor-related conditions |
| GB201815696D0 (en) * | 2018-09-26 | 2018-11-07 | Mereo Biopharma 1 Ltd | Synthetic method |
| GB201815695D0 (en) | 2018-09-26 | 2018-11-07 | Mereo Biopharma 1 Ltd | Synthetic method |
| WO2023158802A1 (en) * | 2022-02-18 | 2023-08-24 | Full-Life Technologies U.S. Inc. | Compounds and radioligands for targeting neurotensin receptor and uses thereof |
| US12091454B2 (en) | 2022-12-28 | 2024-09-17 | Development Center For Biotechnology | Humanized anti-human neurotensin receptor 1 antibodies and their uses |
| WO2025146126A1 (en) * | 2024-01-04 | 2025-07-10 | Full-Life Technologies Hk Limited | Preparation method of compounds targeting neurotensin receptor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE258017C (OSRAM) * | ||||
| DE404647C (de) * | 1922-11-18 | 1924-10-20 | Chemische Ind Ges | Verfahren zur Herstellung von Pyrazolonfarbstoffen |
| US3520926A (en) * | 1966-11-14 | 1970-07-21 | Hoffmann La Roche | Methylhydrazinomethyl-substituted benzoic acid amides |
| US4105766A (en) * | 1977-08-19 | 1978-08-08 | Sterling Drug Inc. | 4,5-Dihydro-5-oxopyrazolo[1,5-a]quinazoline-3-carboxylic acid derivatives |
| GB9004435D0 (en) * | 1990-02-28 | 1990-04-25 | Marconi Co Ltd | Geostationary satellite |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2711140B1 (fr) * | 1993-10-12 | 1996-01-05 | Sanofi Sa | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
| FR2732967B1 (fr) | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
-
1995
- 1995-04-11 FR FR9504350A patent/FR2732967B1/fr not_active Expired - Fee Related
-
1996
- 1996-04-09 IL IL11786096A patent/IL117860A0/xx unknown
- 1996-04-10 US US08/630,761 patent/US5723483A/en not_active Expired - Fee Related
- 1996-04-10 IN IN779DE1996 patent/IN185700B/en unknown
- 1996-04-10 TW TW085104264A patent/TW411332B/zh not_active IP Right Cessation
- 1996-04-11 NZ NZ307227A patent/NZ307227A/xx unknown
- 1996-04-11 EE EE9700264A patent/EE9700264A/xx unknown
- 1996-04-11 EP EP96913568A patent/EP0820444A1/fr not_active Withdrawn
- 1996-04-11 EP EP01102661A patent/EP1097921A1/fr not_active Ceased
- 1996-04-11 JP JP8530771A patent/JP3061644B2/ja not_active Expired - Fee Related
- 1996-04-11 ZA ZA962886A patent/ZA962886B/xx unknown
- 1996-04-11 HU HU9801435A patent/HUP9801435A3/hu unknown
- 1996-04-11 WO PCT/FR1996/000546 patent/WO1996032382A1/fr not_active Application Discontinuation
- 1996-04-11 KR KR1019970707194A patent/KR100366118B1/ko not_active Expired - Fee Related
- 1996-04-11 TR TR97/01146T patent/TR199701146T1/xx unknown
- 1996-04-11 CN CN96193871A patent/CN1072210C/zh not_active Expired - Fee Related
- 1996-04-11 CA CA002220827A patent/CA2220827A1/en not_active Abandoned
- 1996-04-11 AU AU56516/96A patent/AU709119B2/en not_active Ceased
- 1996-04-11 CZ CZ19973232A patent/CZ292255B6/cs not_active IP Right Cessation
- 1996-04-11 UA UA97104992A patent/UA66750C2/xx unknown
- 1996-04-11 PL PL96322723A patent/PL188077B1/pl not_active IP Right Cessation
- 1996-04-11 RU RU97118680/04A patent/RU2195455C2/ru not_active IP Right Cessation
- 1996-04-11 SK SK1367-97A patent/SK136797A3/sk unknown
- 1996-04-11 AR ARP960102151A patent/AR003940A1/es not_active Application Discontinuation
- 1996-04-11 MY MYPI96001383A patent/MY114424A/en unknown
-
1997
- 1997-10-09 IS IS4582A patent/IS4582A/is unknown
- 1997-10-10 NO NO974702A patent/NO310071B1/no not_active IP Right Cessation
- 1997-11-21 US US08/976,309 patent/US5965579A/en not_active Expired - Fee Related
- 1997-11-24 US US08/976,691 patent/US5925661A/en not_active Expired - Fee Related
- 1997-11-24 US US08/977,496 patent/US5939449A/en not_active Expired - Fee Related
- 1997-11-24 US US08/976,714 patent/US5936123A/en not_active Expired - Fee Related
-
1999
- 1999-08-16 US US09/374,697 patent/US6172239B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY114424A (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors,their preparation and pharmaceutical compositions containing them | |
| Bergeron | Methods for the selective modification of spermidine and its homologs | |
| ES8800269A1 (es) | Un procedimiento para la preparacion de peptidilaminodioles. | |
| IL119729A0 (en) | Heterocyclic compounds having tachykinin receptor antagonist activity pharmaceutical compositions containing the same and processes for the preparation thereof | |
| DE19882893T1 (de) | Herstellung von 3-substituierten Adeninen | |
| DE69205327D1 (de) | Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente. | |
| AU1324595A (en) | Cyclic polyamines | |
| TW365602B (en) | New farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain them | |
| NZ505675A (en) | N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents | |
| HUP9802426A2 (hu) | 2,4-Diamino-1,3,5-triazin-származékok, eljárás előállításukra és ezeket tartalmazó herbicid és növekedésszabályozó készítmények | |
| IL104567A (en) | Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| EP1245249A3 (fr) | Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament | |
| DE69120664D1 (de) | Brennstoffzusammensetzungen welche hydroxyalkyl-substituierte amine enthalten | |
| EP0775487A4 (en) | TRIAZINE DERIVATIVE AND MEDICINE | |
| PL322944A1 (en) | Benzimidazolic compounds, pharmaceutic compositions containing such compounds and their application | |
| BG100883A (en) | Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors | |
| BG106814A (en) | Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals | |
| ATE408595T1 (de) | Verbindungen, aus der verbindung hergestelltes polymer und das polymer enthaltende mischung | |
| FI951555A0 (fi) | 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
| GB9516929D0 (en) | Pigment compositions | |
| TW355124B (en) | Substituted pyrazolylpyrazole derivatives and their use as herbicides | |
| HUP9802568A2 (hu) | Glutamát-receptor antagonista hatású szubsztituált-kinoxalin-2,3-dionok alkil-amin-származékai és ezeket tartalmazó gyógyszerkészítmények | |
| GB9720270D0 (en) | Medicaments for the treatment of migraine | |
| HU9402509D0 (en) | N,n'-disubstituted amine derivative | |
| TW372963B (en) | Substituted cycloalkylamino and cycloalkoxy heterocycles, processes for preparing them and their use as pesticides and fungicides |